Report : South Africa Embolotherapy Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (Embolic Agents and Support Devices), Disease Indication (Cancer, Peripheral Vascular Disease, Neurological Diseases, Urological & Nephrological Disorders, Gastrointestinal Disorders, and Others), Procedure (Transcatheter Arterial Embolization (TAE), Transcatheter Arterial Radioembolization (TARE)/Selective Internal Radiation Therapy (SIRT), and Transarterial Chemoembolization (TACE)), and End User (Hospitals & Clinics, Ambulatory Surgery Centers, and Other End Users)
Embolic Agent Segment to Lead Market during 2022–2028
According to our new research study on “South Africa Embolotherapy Market to 2028 – COVID-19 Impact and Global Analysis – by Type, Disease Indication, Procedure, and End User,” the market is expected to reach US$ 65.47 million by 2028 from US$ 42.09 million in 2021; it is expected to grow at a CAGR of 6.5% during 2022–2028. The report highlights trends prevailing in the market and factors driving its growth
The market growth is mainly attributed to factors such as the growing prevalence of hepatocellular cancer and liver cancer, coupled with an increasing focus of the major manufacturers on technological advancements, propelling the growth in the demand for embolotherapy.
Based on product type, the embolotherapy market is segmented into embolic agents and support devices. The embolic agents segment is expected to hold a larger market share in 2022. However, the embolic agents’ segment is anticipated to register the highest CAGR in the market during the forecast period. Rising expenditure to develop healthcare infrastructure coupled with rising research and development proficiencies to make advancements in healthcare technology is propelling growth in the embolotherapy market. Increasing patient preference for minimally invasive procedures and increasing personal disposable income are other market growth determinants.
Impact of COVID-19 Pandemic on Artificial Cornea and Corneal Implant Market:
The COVID-19 pandemic adversely affected industries worldwide. The COVID-19 outbreak led to significant disruptions in primary industries, such as manufacturing, healthcare, energy & power, electronics & semiconductor, aerospace & defense, and construction in 2020. In response to the need to control the spread of the COVID-19 infection among people, hospitals discontinued several services and redirected their operations toward managing the disease. Moreover, hospitals and healthcare providers reassigned their specialist doctors to various ICU tasks and other COVID-19-related wards. Care receivers also avoided clinic visits for non-lethal conditions in the first and second quarters of 2020. According to an article in Ophthalmology Times, elective procedures decreased from 200 to only 10 per week in 2020. These conditions resulted in the slow growth of the artificial cornea and corneal implant market.
Abbott Laboratories, Boston Scientific Corporation, Cook Medical LLC, Johnson & Johnson ConsumerInc, Medtronic, Acandis GmbH, Terumo Corporation, Balt USA LLC, Stryker Corporation, and Guerbet LLC are leading companies South Africa Embolotherapy Market
The report segments the South Africa Embolotherapy market as follows:
The South Africa Embolotherapy market is segmented into product, disease indication type, procedure, and end user. Based on product, the market is segmented into embolic agents and support devices. Based on disease indication, the market is segmented into cancer, peripheral vascular disease, neurological diseases, urological and nephrological disorders, gastrointestinal disorders, and others. Based on procedure, the market is segmented into transcatheter arterial embolization (TAE), transcatheter arterial radioembolization (TARE)/selective internal radiation therapy (SIRT), and transarterial chemoembolization (TACE). Based on end user, the market is segmented into hospitals & clinics, ambulatory surgery centers, and other end users
Contact Person: Sameer Joshi
Phone: +1- 646- 491- 9876
Email Id: email@example.com